RIGL
Rigel Pharmaceuticals IncCompany with tickers: RIGL
Market Cap
$684.39M
Shares Outstanding
18,502,080
CIK
1034842
CUSIP
766559702
13F Activity (30d)
4 filings
3 filers
Website
Visit website
Investor Relations
Investor relations
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Cash spent on buybacks by quarter
Cash deployed each quarter.
Repurchase History
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 | $3,740,000 | 10-Q, filed 2026-05-05 |
| 2025-03-31 | $0 | 10-Q, filed 2026-05-05 |